Golden Remedies Profile
Key Indicators
- Authorised Capital ₹ 3.00 M
- Paid Up Capital ₹ 2.50 M
- Company Age 29 Year, 5 Months
- Last Filing with ROC 31 Mar 2024
- Satisfied Charges ₹ 8.51 M
- Revenue Growth 17.62%
- Profit Growth 4.65%
- Ebitda -2509.42%
- Net Worth -64.08%
- Total Assets 13.35%
About Golden Remedies
Golden Remedies Private Limited (GRPL) is a Private Limited Indian Non-Government Company incorporated in India on 21 August 1995 and has a history of 29 years and five months. Its registered office is in Chandigarh, India.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 3.00 M and a paid-up capital of Rs 2.50 M.
The company has closed loans amounting to ₹8.51 M, and has no open charges as per Ministry of Corporate Affairs (MCA) records.
Luxmi Garg, Vijender Garg, Surinder Garg, and Two other members serve as directors at the Company.
Company Details
- Location
Chandigarh, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
-
- Social Media-
Corporate Identity Details
- CIN/LLPIN
U24231CH1995PTC016918
- Company No.
016918
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
21 Aug 1995
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Chandigarh
Industry
Who are the key members and board of directors at Golden Remedies?
Board Members (5)
Name | Designation | Appointment Date | Status |
---|---|---|---|
Sumit Sharan | Director | 07-Jan-2013 | Current |
Aditya Garg | Additional Director | 17-Jun-2024 | Current |
Luxmi Garg | Director | 01-May-2000 | Current |
Vijender Garg | Director | 24-Mar-2003 | Current |
Surinder Garg | Director | 19-Dec-2011 | Current |
Financial Performance of Golden Remedies.
Golden Remedies Private Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 17.62% increase. The company also saw a slight improvement in profitability, with a 4.65% increase in profit. The company's net worth observed a substantial decline by a decrease of 64.08%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
---|---|---|---|---|---|---|---|
Total Revenue |
| ||||||
Revenue from Operations | |||||||
Total Assets |
| ||||||
Profit or Loss |
| ||||||
Net Worth |
| ||||||
EBITDA |
|
What is the Ownership and Shareholding Structure of Golden Remedies?
In 2020, Golden Remedies had a promoter holding of 8.00% and a public holding of 92.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
₹0
₹8.51 M
Charges Breakdown by Lending Institutions
- The Haryana Financial Corp. : 0.53 Cr
- Hdfc Bank Limited : 0.32 Cr
Latest Charge Details
Date | Lender | Amount | Status |
---|---|---|---|
18 Mar 2016 | Hdfc Bank Limited | ₹3.20 M | Satisfied |
12 Jun 1996 | The Haryana Financial Corp. | ₹5.31 M | Satisfied |
How Many Employees Work at Golden Remedies?
Unlock and access historical data on people associated with Golden Remedies, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Golden Remedies, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Golden Remedies's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.